Record Information
Version1.0
Creation Date2009-03-06 18:58:14 UTC
Update Date2026-05-14 16:59:53 UTC
Accession NumberCHEM000169
Identification
Common NameAluminum
ClassSmall Molecule
DescriptionAluminium is a soft, lightweight metal with appearance ranging from silvery to dull gray, depending on the surface roughness. Data indicate that aluminum contaminates much of the raw material used to manufacture solutions used for intravenous nutritional support of hospitalized and ambulatory patients, and that pharmaceutical manufacturers have only recently obtained the technology necessary to detect aluminum contamination of their products. As a result, aluminum bypassed normal barriers and entered the blood, accumulating in tissues such as bone, liver and the central nervous system with toxic consequences. Now that the FDA has finally issued a rule governing aluminum contamination in these solutions, manufacturers will need to develop methods to minimize such contamination; scientists should also realize that when data they obtain indicate a serious problem in the manufacturing sector they should be sure that the problem is properly addressed. Physiologically, this metal/element. exists as an ion in the body. (3).
Contaminant Sources
  • Clean Air Act Chemicals
  • EAFUS Chemicals
  • FooDB Chemicals
  • HMDB Contaminants - Urine
  • HPV EPA Chemicals
  • T3DB toxins
Contaminant Type
  • Aluminum Compound
  • Cosmetic Toxin
  • Drug
  • Food Toxin
  • Household Toxin
  • Human Neurotoxin
  • Industrial/Workplace Toxin
  • Inorganic Compound
  • Metabolite
  • Metal
  • Natural Compound
Chemical Structure
Thumb
Synonyms
ValueSource
13AlChEBI
AlChEBI
AluminioChEBI
AluminiumChEBI
Aluminium-27HMDB
Aluminium 27HMDB
Aluminum 27HMDB
Aluminum-27HMDB
AluminumChEBI
Chemical FormulaAl
Average Molecular Mass26.982 g/mol
Monoisotopic Mass26.982 g/mol
CAS Registry Number7429-90-5
IUPAC Namealuminium
Traditional Namealumane
SMILES[Al]
InChI IdentifierInChI=1S/Al
InChI KeyXAGFODPZIPBFFR-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of inorganic compounds known as homogeneous post-transition metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a post-transition metal atom.
KingdomInorganic compounds
Super ClassHomogeneous metal compounds
ClassHomogeneous post-transition metal compounds
Sub ClassNot Available
Direct ParentHomogeneous post-transition metal compounds
Alternative ParentsNot Available
Substituents
  • Homogeneous post-transition metal
Molecular FrameworkNot Available
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Cytoplasm
  • Extracellular
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Physical Properties
StateSolid
AppearanceSilvery white metallic solid.
Experimental Properties
PropertyValue
Melting Point2.375 g*Cm -3
Boiling Point2327°C (4220.6°F)
SolubilityNot Available
Predicted Properties
PropertyValueSource
logP1.45ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity0 m³·mol⁻¹ChemAxon
Polarizability1.78 ųChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-001i-9000000000-9378da25f3a524cf38e8Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-001i-9000000000-9378da25f3a524cf38e8Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-001i-9000000000-9378da25f3a524cf38e8Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-001i-9000000000-71051ebfdb9ee6a6ce2dSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-001i-9000000000-71051ebfdb9ee6a6ce2dSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-001i-9000000000-71051ebfdb9ee6a6ce2dSpectrum
Toxicity Profile
Route of ExposureOral (25) ; inhalation (25)
Mechanism of ToxicityThe main targets of aluminum are the central nervous system and bones. Aluminum binds to dietary phosphorus and impairs gastrointestinal absorption of phosphorus. The decreased phosphate body burden results in osteomalacia and rickets. Aluminum's neurotoxicity is believed to involve different mechanisms. Changes in cytoskeletal protein functions as a result of altered phosphorylation, proteolysis, transport, and synthesis are believed to be one cause. Aluminum may induce neurobehavioral effects by affecting permeability of the blood-brain barrier, cholinergic activity, signal transduction pathways, lipid peroxidation, and impair neuronal glutamate nitric oxide-cyclic GMP pathway, as well as interfere with metabolism of essential trace elements because of similar coordination chemistries and consequent competitive interactions. It has been suggested that aluminum's interaction with estrogen receptors increases the expression of estrogen-related genes and thereby contributes to the progression of breast cancer (1), but studies have not been able to establish a clear link between aluminum and increased risk of breast cancer (22). Certain aluminum salts induce immune responses by activating inflammasomes. (25, 1, 2) Aluminum Acetate is an astringent. An astrignent is a chemical that tends to shrink or constrict body tissues, usually locally after topical medicinal application. The shrinkage or constriction is through osmotic flow of water (or other fluids) away from the area where the astringent was applied. Astringent medicines cause shrinkage of mucous membranes or exposed tissues and are often used internally to check discharge of blood serum or mucous secretions. This can happen with a sore throat, hemorrhages, diarrhea, or with peptic ulcers. Externally applied astringents, which cause mild coagulation of skin proteins, dry, harden, and protect the skin. Acne sufferers are often advised to use astringents if they have oily skin. Astringents also help heal stretch marks and other scars. Mild astringent solutions are used in the relief of such minor skin irritations as those resulting from superficial cuts, allergies, insect bites, or fungal infections such as athlete's foot.
MetabolismAluminum is poorly absorbed following oral or inhalation exposure and is essentially not absorbed dermally. The bioavailability of aluminum is strongly influenced by the aluminum compound and the presence of dietary constituents which can complex with aluminum and enhance or inhibit its absorption. Aluminum binds to various ligands in the blood and distributes to every organ, with highest concentrations found in bone and lung tissues. In living organisms, aluminum is believed to exist in four different forms: as free ions, as low-molecular-weight complexes, as physically bound macromolecular complexes, and as covalently bound macromolecular complexes. Absorbed aluminum is excreted principally in the urine and, to a lesser extent, in the bile, while unabsorbed aluminum is excreted in the faeces. (25)
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)Not listed by IARC. IARC classified aluminum production as carcinogenic to humans (Group 1), but did not implicate aluminum itself as a human carcinogen. (24) A link between use of aluminum-containing antiperspirants and increased risk of breast cancer has been proposed (1), but studies have not been able to establish a clear link (22).
Uses/SourcesAluminum is used for beverage cans, pots and pans, airplanes, siding and roofing, and foil. It is often mixed with small amounts of other metals to form aluminum alloys, which are stronger and harder. Aluminum compounds have many different uses, for example, as alums in water-treatment and alumina in abrasives and furnace linings. They are also found in consumer products such as antacids, astringents, buffered aspirin, food additives, cosmetics, and antiperspirants. (25, 26)
Minimum Risk LevelIntermediate Oral: 1.0 mg/kg/day (23) Chronic Oral: 1.0 mg/kg/day (23)
Health EffectsAluminum targets the nervous system and causes decreased nervous system performance and is associated with altered function of the blood-brain barrier. The accumulation of aluminum in the body may cause bone or brain diseases. High levels of aluminum have been linked to Alzheimer’s disease. A small percentage of people are allergic to aluminium and experience contact dermatitis, digestive disorders, vomiting or other symptoms upon contact or ingestion of products containing aluminium. (25, 26)
SymptomsInhalating aluminum dust causes coughing and abnormal chest X-rays. A small percentage of people are allergic to aluminium and experience contact dermatitis, digestive disorders, vomiting or other symptoms upon contact or ingestion of products containing aluminium. (25, 26)
TreatmentNot Available
Concentrations
Not Available
DrugBank IDDB01370
HMDB IDHMDB0001247
FooDB IDFDB003570
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkAluminium
Chemspider ID4514248
ChEBI ID28984
PubChem Compound ID5359268
Kegg Compound IDC06264
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis Reference

Bela Czegledi, Mihaly Csovari, Miklos Erdelyi, Lajos Streker, Istvan Toth, Katalin Szabo nee Mogyorosi, Szilard Riederauer, Geza Szentgyorgyi, “Process for producing alumina and ferric oxide from aluminium carriers with high iron and silicon content.” U.S. Patent US4366129, issued 1876.

MSDSLink
General References
1. Kang, B. S.; Kim, W. B.; Park, Y. S.; Yoo, Y. H. Recovery of aluminum from anthracite ash. Konghak Nonjip (1989), 30 57-70.
2. Strunecka A, Strunecky O, Patocka J: Fluoride plus aluminum: useful tools in laboratory investigations, but messengers of false information. Physiol Res. 2002;51(6):557-64.
3. Elmore AR: Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, Fuller's earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite. Int J Toxicol. 2003;22 Suppl 1:37-102.
4. Savory J, Herman MM, Ghribi O: Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain. J Inorg Biochem. 2003 Sep 15;97(1):151-4.
5. Arnold CJ, Miller GG, Zello GA: Parenteral nutrition-associated cholestasis in neonates: the role of aluminum. Nutr Rev. 2003 Sep;61(9):306-10.
6. Zatta P, Lucchini R, van Rensburg SJ, Taylor A: The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull. 2003 Nov 15;62(1):15-28.
7. Gherardi RK, Authier FJ: Aluminum inclusion macrophagic myofasciitis: a recently identified condition. Immunol Allergy Clin North Am. 2003 Nov;23(4):699-712.
8. Becaria A, Campbell A, Bondy SC: Aluminum as a toxicant. Toxicol Ind Health. 2002 Aug;18(7):309-20.
9. Klein GL: Aluminum: new recognition of an old problem. Curr Opin Pharmacol. 2005 Dec;5(6):637-40. Epub 2005 Sep 28.
10. Kawahara M: Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis. 2005 Nov;8(2):171-82; discussion 209-15.
11. Aremu DA, Meshitsuka S: Some aspects of astroglial functions and aluminum implications for neurodegeneration. Brain Res Rev. 2006 Aug 30;52(1):193-200. Epub 2006 Mar 10.
12. Perl DP, Moalem S: Aluminum and Alzheimer's disease, a personal perspective after 25 years. J Alzheimers Dis. 2006;9(3 Suppl):291-300.
13. Savory J, Herman MM, Ghribi O: Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease. J Alzheimers Dis. 2006 Nov;10(2-3):135-44.
14. Campbell A: The role of aluminum and copper on neuroinflammation and Alzheimer's disease. J Alzheimers Dis. 2006 Nov;10(2-3):165-72.
15. Miu AC, Benga O: Aluminum and Alzheimer's disease: a new look. J Alzheimers Dis. 2006 Nov;10(2-3):179-201.
16. Yokel RA: Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J Alzheimers Dis. 2006 Nov;10(2-3):223-53.
17. Domingo JL: Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents. J Alzheimers Dis. 2006 Nov;10(2-3):331-41.
18. Riggs K, Keller M, Humphreys TR: Ablative laser resurfacing: high-energy pulsed carbon dioxide and erbium:yttrium-aluminum-garnet. Clin Dermatol. 2007 Sep-Oct;25(5):462-73.
19. Hem SL, Hogenesch H: Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev Vaccines. 2007 Oct;6(5):685-98.
20. Nokleby H: Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine. Expert Rev Vaccines. 2007 Oct;6(5):863-9.